These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 7539508)

  • 21. A Recombinant Hepatitis C Virus Genotype 1a E1/E2 Envelope Glycoprotein Vaccine Elicits Antibodies That Differentially Neutralize Closely Related 2a Strains through Interactions of the N-Terminal Hypervariable Region 1 of E2 with Scavenger Receptor B1.
    Johnson J; Freedman H; Logan M; Wong JAJ; Hockman D; Chen C; He J; Beard MR; Eyre NS; Baumert TF; Tyrrell DL; Law JLM; Houghton M
    J Virol; 2019 Nov; 93(22):. PubMed ID: 31462563
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Induction of cross-reactive humoral immune response by immunization with mimotopes of the hypervariable region 1 of the hepatitis C virus.
    Roccasecca R; Folgori A; Ercole BB; Puntoriero G; Lahm A; Zucchelli S; Tafi R; Pezzanera M; Galfre G; Tramontano A; Mondelli MU; Pessi A; Nicosia A; Cortese R; Meola A
    Int Rev Immunol; 2001; 20(2):289-300. PubMed ID: 11878771
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Study of neutralization antibodie induced by DNA vaccine of HCV envelope protein 2 in mice].
    Shao S; Zhou H; Tong Y; Ren Y; Chen Z
    Wei Sheng Yan Jiu; 2011 May; 40(3):295-8. PubMed ID: 21695897
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In vivo and in vitro evidence that cross-reactive antibodies to C-terminus of hypervariable region 1 do not neutralize heterologous hepatitis C virus.
    Esumi M; Zhou YH; Tanoue T; Tomoguri T; Hayasaka I
    Vaccine; 2002 Aug; 20(25-26):3095-103. PubMed ID: 12163260
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A hyperimmune serum against a synthetic peptide corresponding to the hypervariable region 1 of hepatitis C virus can prevent viral infection in cell cultures.
    Shimizu YK; Igarashi H; Kiyohara T; Cabezon T; Farci P; Purcell RH; Yoshikura H
    Virology; 1996 Sep; 223(2):409-12. PubMed ID: 8806581
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mimotopes of the hepatitis C virus hypervariable region 1, but not the natural sequences, induce cross-reactive antibody response by genetic immunization.
    Zucchelli S; Roccasecca R; Meola A; Ercole BB; Tafi R; Dubuisson J; Galfré G; Cortese R; Nicosia A
    Hepatology; 2001 Mar; 33(3):692-703. PubMed ID: 11230750
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A correlation between the heterogeneity of hypervariable region 1 of E2 glycoprotein of Hepatitis C virus (HCV) and HCV antibody profile: a case study.
    Kmieciak D; Biernacka-Lukanty J; Migdalski P; Turek-Plewa J; Wierzbicki A; Juszczyk J; Trzeciak WH
    Acta Virol; 2005; 49(2):97-103. PubMed ID: 16047736
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Viral persistence, antibody to E1 and E2, and hypervariable region 1 sequence stability in hepatitis C virus-inoculated chimpanzees.
    Bassett SE; Thomas DL; Brasky KM; Lanford RE
    J Virol; 1999 Feb; 73(2):1118-26. PubMed ID: 9882313
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sequence evolution of the hypervariable region in the putative envelope region E2/NS1 of hepatitis C virus is correlated with specific humoral immune responses.
    van Doorn LJ; Capriles I; Maertens G; DeLeys R; Murray K; Kos T; Schellekens H; Quint W
    J Virol; 1995 Feb; 69(2):773-8. PubMed ID: 7815542
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Patients infected with the same hepatitis C virus strain display different kinetics of the isolate-specific antibody response.
    Allander T; Beyene A; Jacobson SH; Grillner L; Persson MA
    J Infect Dis; 1997 Jan; 175(1):26-31. PubMed ID: 8985192
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Network Analysis of the Chronic Hepatitis C Virome Defines Hypervariable Region 1 Evolutionary Phenotypes in the Context of Humoral Immune Responses.
    Palmer BA; Schmidt-Martin D; Dimitrova Z; Skums P; Crosbie O; Kenny-Walsh E; Fanning LJ
    J Virol; 2015 Dec; 90(7):3318-29. PubMed ID: 26719263
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Development of a plant-derived subunit vaccine candidate against hepatitis C virus.
    Nemchinov LG; Liang TJ; Rifaat MM; Mazyad HM; Hadidi A; Keith JM
    Arch Virol; 2000; 145(12):2557-73. PubMed ID: 11205105
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Broadly cross-reactive mimotope of hypervariable region 1 of hepatitis C virus derived from DNA shuffling and screened by phage display library.
    Zhang XX; Deng Q; Zhang SY; Liu J; Cai Q; Lu ZM; Wang Y
    J Med Virol; 2003 Dec; 71(4):511-7. PubMed ID: 14556263
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Human recombinant single-chain antibody fragments, specific for the hypervariable region 1 of hepatitis C virus, from immune phage-display libraries.
    Zhai W; Davies J; Shang DZ; Chan SW; Allain JP
    J Viral Hepat; 1999 Mar; 6(2):115-24. PubMed ID: 10607222
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antibody Response to Hypervariable Region 1 Interferes with Broadly Neutralizing Antibodies to Hepatitis C Virus.
    Keck ZY; Girard-Blanc C; Wang W; Lau P; Zuiani A; Rey FA; Krey T; Diamond MS; Foung SK
    J Virol; 2016 Jan; 90(6):3112-22. PubMed ID: 26739044
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Variations in the hypervariable region 1 of the envelope region E2 of hepatitis C virus RNA appear associated with virus persistence independently of liver disease.
    Brunetto MR; Suzuki T; Aizaky H; Flichman D; Colombatto P; Abate ML; Oliveri F; Matsuura Y; Bonino F; Miyamura T
    Ital J Gastroenterol; 1996 Dec; 28(9):499-504. PubMed ID: 9131394
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Peptide immunogen mimicry of putative E1 glycoprotein-specific epitopes in hepatitis C virus.
    Ray R; Khanna A; Lagging LM; Meyer K; Choo QL; Ralston R; Houghton M; Becherer PR
    J Virol; 1994 Jul; 68(7):4420-6. PubMed ID: 8207814
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Experimental vaccine activities of recombinant E1 and E2 glycoproteins and hypervariable region 1 peptides of hepatitis C virus in chimpanzees.
    Esumi M; Rikihisa T; Nishimura S; Goto J; Mizuno K; Zhou YH; Shikata T
    Arch Virol; 1999; 144(5):973-80. PubMed ID: 10416378
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Early antibody response against hypervariable region 1 is associated with acute self-limiting infections of hepatitis C virus.
    Zibert A; Meisel H; Kraas W; Schulz A; Jung G; Roggendorf M
    Hepatology; 1997 May; 25(5):1245-9. PubMed ID: 9141445
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Reactivity of synthetic peptides representing selected sections of hepatitis C virus core and envelope proteins with a panel of hepatitis C virus-seropositive human plasma.
    Jackson P; Petrik J; Alexander GJ; Pearson G; Allain JP
    J Med Virol; 1997 Jan; 51(1):67-79. PubMed ID: 8986952
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.